Showing results (31-40 of 111) with videos related to
Sort By:
Pageof 12
Cancer|May 3, 2017
Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: A population-based studyAshley M Perry, Andrew M Brunner, Tao Zou, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2013
Treatment-related toxicities in a phase II trial of dasatinib in patients with squamous cell carcinoma of the lungAndrew M Brunner, Daniel B Costa, Rebecca S Heist, et al.Cancers|November 13, 2021
<i>TP53</i> Combined Phenotype Score Is Associated with the Clinical Outcome of <i>TP53</i>-Mutated Myelodysplastic SyndromesMariko Yabe, Aidana Z Omarbekova, Meier Hsu, et al.Cancer|August 9, 2020
Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromesCharlotte K Brierley, Emily C Zabor, Rami S Komrokji, et al.JCO Precision Oncology|February 17, 2022
Combined Targeted Therapy for <i>BRAF</i>-Mutant, Treatment-Related Acute Myeloid LeukemiaSeth A Wander, Robert P Hasserjian, Kwadwo Oduro, et al.Blood Advances|October 5, 2021
Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium TrialsYannis K Valtis, Kristen E Stevenson, Andrew E Place, et al.Leukemia Research|May 6, 2014
Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: a SEER database analysisAndrew M Brunner, Traci M Blonquist, Hossein Sadrzadeh, et al.The Oncologist|May 31, 2022
Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and ImmunotherapyValentina Nardi, Steven L McAfee, Paola Dal Cin, et al.Therapeutic Advances in Hematology|September 18, 2024
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasmsJustin Watts, Mark D Minden, Kimo Bachiashvili, et al.Leukemia & Lymphoma|September 13, 2014
Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysisMaryam Movassaghian, Andrew M Brunner, Traci M Blonquist, et al.Pageof 12